Sign In
 [New User? Sign Up]
Mobile Version

Director, Health Economics & Outcomes Research, Ibrance, Oncology


New York, NY
Apply on the Company Site
  • Save Ad
  • Email Friend
  • Print
  • Research Salary

Job Details

+ This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance, executing and communicating evidence generated to demonstrate the value of Ibrance. To develop and execute on the HEOR strategy supporting the overall strategic goals of the Oncology BU by demonstrating competitive differentiation, achieving optimal reimbursement and maintaining lead in market share for Ibrance amongst the CDK inhibitorsThe Health Economics & Outcomes Research (HEOR) Director will work in a closely aligned fashion with the Senior Director/Team Lead, Oncology PHI Cross-Functional Leadership Team (CFLT) and other functional areas within PHI as well as the brand team to ensure there is a single and coordinated view on strategy and delivery from PHI to the Oncology BU. The HEOR Director will be a strategic partner to the Global/US Ibrance cross functional Team and implement an HEOR strategy that supports and help communicate the overall asset value proposition.

+ Minimum: Masters degree (MSc, MPH) in health services research, pharmacy administration/pharmaceutical policy, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in pharmaceutical administration/ pharmaceutical policy, health services research, public health, epidemiology, or health economics.

+ Minimum 8 years' experience in health outcomes and related fields, 5 of which are as part of global health economics and/or outcomes research teams in a global pharmaceutical company.

+ Knowledge and experience in the oncology therapeutic area is preferred

+ Strong working knowledge of the technical and methodological aspects of clinical trial and real world study design and implementation.

+ Demonstrated capability independently managing diverse projects ranging from economic analyses, patient reported outcomes to real world database studies.

+ Strong methodological skills (study design, data analysis and interpretation) in cancer health services research is required

+ Experience with regulatory submissions and interactions with regulatory authorities is desirable

+ Global launch experience is desirable

+ In depth understanding of Pharmacoeconomics and psychometrics/patient reported outcomes is required

+ Knowledge of health care systems and reimbursement processes in key markets and experience with HTA organizations such as NICE, SMC, IQWIG/G-BA, PBAC is desirable

+ Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers and influence in a matrix environment

+ Excellent oral and written English communication skills required

+ Strong publication record is desirable

+ Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities

+ Demonstrated ability to influence key members of medical and commercial teams constructively and without conflict in a matrix environment

+ Skilled in functioning within a matrix organization where managing through influence is required

+ Lead development of the HEOR strategy to support the value of assets in the Oncology Business Unit.

+ Lead the execution of clinically relevant and scientifically valid, cutting edge HEOR studies and projects (including non-interventional studies, registries, etc.) in alignment with the global HEOR strategy catered to diverse stakeholders (regulators, payers, patients, physicians and policy makers)

+ Incorporate relevant patient centric and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy & access targets for the asset(s)

+ Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable demonstration of robust incremental clinical value over standard of care that can facilitate optimal patient access.

+ Selection, related analyses, interpretation and communication of Patient Reported Outcomes(PRO) measures as appropriate for clinical trials, registries, and prospective real world studies.

+ Lead the timely development of post launch deliverables including update of value dossiers (GVDs, AMCP), economic models, and innovative tools to successfully support reimbursement.

+ Lead the coordination of input from Pfizer local country/regional H&V teams on evidence needs and ensure that the input is appropriately incorporated to support demonstration of product value and optimize patient access.

+ Develop real world evidence generation strategies and execute studies (e.g. treatment patterns, real world effectiveness, burden of illness studies, epidemiology studies, etc) to generate evidence to support brand competitive differentiation and value proposition.

+ Collaborate with Pfizer local country affiliates, conduct training on economic models and enable local model adaptations and updates throughout the product life cycle.

+ Provide strategic and content guidance in reimbursement (re)negotiations for Pfizer products.

+ Lead the development of appropriate data dissemination plans and communicate in a timely manner evidence generated to various stakeholders via publications and conference presentations.

+ Optimal project Budget management

**EEO & Employment Eligibility**

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

**Sunshine Act**

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

**Other Job Details:**

+ **Last Date to Apply for Job: January 12, 2018**

+ **Locations - this position can be home based or at any Pfizer location in North America; Collegeville PA, New York NY, La Jolla CA**

Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Apply on the Company Site
Powered ByLogo

Featured Jobs[ View All ]

Featured Employers [ View All ]